ADPT

27.9300.43%
CM

Chad M. Robins

Co-Founder, CEO & Chairman

Mr. Chad M. Robins, M.B.A., serves as Independent Director at CM Life Sciences III Inc. since April 07, 2021. He serves as an Independent Director at ARYA Sciences Acquisition Corp II since June 2020. He co-founded Adaptive Biotechnologies Corporation in September 2009 and has served as its Chief Executive Officer and Director since incorporation. Prior to co-founding Adaptive Biotechnologies Corporation, Mr. Robins held numerous executive-level positions in medical technology, investment and real estate companies. He held a corporate finance position at Bank of America. He opened the West Coast office of Wasserstein Perella’s software and internet services group before moving to the operating side to run the West Coast office of a publicly traded online health insurance company, HealthAxis.com. Post Wharton, he served as Vice President of Operations for Pulte Homes (NYSE:PHM) and Chief Operating Officer for Connaught Real Estate Finance, an opportunistic hedge fund. He served as a Member of Business Advisory Board at Zentalis Pharmaceuticals, Inc. until 2022. He has been a Director of AltPep Corporation since September 2020 and serves as its Board Chair since 2024. He has also served as the Board of Directors of Life Science Washington since January 2017 and Headlight Technologies, Inc. since July 2014. He also co-founded and served on the Board of Directors for Aortica Corporation from October 2014 to November 2019. He serves as a Director of AdvaMedDx and Pavia Systems, Inc. Mr. Robins holds an MBA from The Wharton School at the University of Pennsylvania and a BS in Managerial Economics from Cornell University.

Positions